Depression and anxiety disorders in patients with multiple sclerosis: association with neurodegeneration and neurofilaments
Braz. j. med. biol. res; 54 (3), 2021
There is increasing evidence that neurofilament light chain (NF-L) can be considered as a biomarker for neuro-axonal damage. This polypeptide can be released into the cerebrospinal fluid (CSF) and the blood, where it can be quantified. The concentration of NF-L is elevated in patients with multiple scler...